Find Clinical Trial

Home » Find Clinical Trials » Evaluation of the clinical efficacy and safety of perindopril 5 mg / indapamide 1.25 mg / amlodipine 5 mg fixed combination in single-pill after 2 months of treatment versus free combination, perindopril 4 mg / indapamide 1.25 mg + amlodipine 5 mg given separately at the same time, with conditional titration based on blood pressure control in patients with essential hypertension uncontrolled after 1 month with perindopril 4 mg / indapamide 1.25 mg bi-therapy. A national, multicentre, randomised, double blind, 7 months study.

Evaluation of the clinical efficacy and safety of perindopril 5 mg / indapamide 1.25 mg / amlodipine 5 mg fixed combination in single-pill after 2 months of treatment versus free combination, perindopril 4 mg / indapamide 1.25 mg + amlodipine 5 mg given separately at the same time, with conditional titration based on blood pressure control in patients with essential hypertension uncontrolled after 1 month with perindopril 4 mg / indapamide 1.25 mg bi-therapy. A national, multicentre, randomised, double blind, 7 months study.

← Back

Study Phase	Phase 3

Therapeutic Area	Cardiovascular Diseases

Indication	Hypertension

Sponsor	Institut de Recherches Internationales Servier (IRIS)

Active substance/ Medical device	AMLODIPINE, INDAPAMIDE, PERINDOPRIL

Active Substance Code	S06593

Protocol Code	CL3-06593-018

NCT Code	NCT05820880

Documents and links

Lay summary

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.